Back to top

Grace Therapeutics advances dual-source manufacturing for GTx-104

Grace Therapeutics ( ($GRCE) ) just unveiled an update. On July 28, 2026, Grace Therapeutics announced it had received formal minutes from an FDA T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Grace Therapeutics, Inc. (GRCE)